2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005
Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection
Avanza on Twitter: "@indexjagaren Innehaven i fonden presenteras efter månadsskiftet, men om du är nyfiken kan du redan nu se de största innehaven i fonden i det här blogginlägget 😄 https://t.co/6ZRyEmYskc" /
Dansk Cardiologisk Selskab
Avanza (@avanzabank) / Twitter
SAS Nordic
The inTandem 2 study: 52-week efficacy and safety of sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in adults with type 1 diabetes - Media Centre | EASD
Josefin Rosén på LinkedIn: Hög tid att accelerera hållbar AI
Diabetes Clinical Guidelines - Alameda Alliance for Health
Per Norhammar (@norhammar) / Twitter
Cristina Lugaro on LinkedIn: Ress Life Investments continues to attract capital in uncertain and…
Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection
Per Norhammar (@norhammar) / Twitter
Anna Norhammar, Hjärt-Lungfondens forskare och docent i kardiologi - Hjärt-Lungfonden
Per Norhammar (@norhammar) / Twitter
Internet of Things Archives - Page 9 of 10 - Hidden Insights
SAS Nordic
Journal of The Brazilian Medical Association
Per Norhammar (@norhammar) / Twitter
Nyfiken på innehaven i Avanza Fastighet by Norhammar?
Life | Free Full-Text | Microvascular and Endothelial Dysfunction in Prediabetes
Frontiers | Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection
